Mouheb, N. Kitous, F. Saidi, F. Toudeft, M. Journal page Archives Contents list. Romain, X. Game, F. Torny, P. Colombeau, J. Dumas, X. Plainard, J. Salle, L. Fourcade, A. OnabotulinumtoxinA U significantly improves bladder: network meta-analyses. Refractory urge urinary incontinence and botuli- a randomised double-blind placebo-controlled trial. J Appl Res ;— Refractory idiopathic urge urinary incontinence and administration of intradetrusor botulinum toxin in intractable botulinum A injection.
J Urol ;— BJU Int ;—6. Recommendations on the use of botulinum overactivity: results from a single center, randomized, double- toxin in the treatment of lower urinary tract disorders and pel- blind, placebo controlled trial.
J Urol ;—6. Improvement in qua- ;— Out- detrusor overactivity: results from a randomized double-blind comes of intravesical botulinum toxin for idiopathic overactive placebo-controlled trial.
Out- ;— J Urol D. Botulinum toxin injections for adults with overactive ;— Preliminary CD Neu- P, Giannantoni A, et al. Contemporary management of lower rourol Urodyn ;—8. Efficacy and safety of onabotuli- linumtoxinA. J Urol F, et al. Urodynamic results and clinical ;— Will suburothelial injection of small dose of botuli- in a randomized, placebo-controlled dose-finding study in idio- num A toxin have similar therapeutic effects and less adverse pathic overactive bladder.
Comment combler les rides du front homme
Neurourol Urodyn ;— Rechberger T, et al. Prescribing information; Comparison of effectiveness of detrusor, suburothelial due to idiopathic overactive bladder: a week, double-blind, and bladder base injections of botulinum toxin A for idiopathic placebo-controlled, randomized, dose-ranging trial.
Eur Urol detrusor overactivity. Treatment satisfaction and goal attainment with onabo- bladder: trigone versus trigone-sparing injection.
Can J Urol tulinumtoxinA in patients with incontinence due to idiopathic ;13 5 —5. Int Urogynecol J ;— Prospective randomized Corcos J. Botulinum toxin type A injections into the trigone to trial of U vs U botox in the treatment of idiopathic treat idiopathic overactive bladder do not induce vesicourete- overactive bladder. Urol Ann ;— Rides went wrong Urol ;—4. Prog controlled trial. Int J Clin Pract ;— Urol ;—7.
Efficacy and safety of low doses of onabotulinum- V, et al. A systematic review and meta-analysis of randomi- toxinA for the treatment of refractory idiopathic overactive zed controlled trials with antimuscarinic drugs for overactive bladder: a multicentre, double-blind, randomised, placebo- bladder. Eur Urol ;—9. Anticholinergic therapy vs. Botulinum toxin A versus placebo for refrac- numtoxinA for urgency urinary incontinence. N Engl J Med tory detrusor overactivity in women: a randomised blinded ;— Lam W, et al.
OnabotulinumtoxinA for the treatment of overactivity. J Urol ;—9. J Efficacy and safety of onabotulinumtoxinA in patients with uri- Urol ;— Study Group. Repeated injections of botulinum toxin-  European Association of Urology, online guidelines A for idiopathic detrusor overactivity. Surgical interventions for refractory DO.
Costa hB. Fatton iX. Deffieux jF. Haab kJ. Hermieu lL. Le Normand mC. Saussine nP. Service de rééducation neurologique, pavillon Netter,boulevard Raymond-Poincaré, Garches, France. Outline Masquer le plan. Matériel et méthodes. Top of the page - Article Outline. Contact Help Who are we? As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.